New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Researchers use imaging technique to predict dementia status in adults with down syndrome

Researchers use imaging technique to predict dementia status in adults with down syndrome

by Laura Dawahare,University of KentuckyResearchers at the University of Kentucky Sanders-Brown Center on Aging found that magnetic resonance spectroscopy (MRS), a noninvasive imaging technique,
Neurology March 07,2024
Researchers use imaging technique to predict dementia status in adults with down syndrome

Researchers use imaging technique to predict dementia status in adults with down syndrome

by Laura Dawahare,University of KentuckyResearchers at the University of Kentucky Sanders-Brown Center on Aging found that magnetic resonance spectroscopy (MRS), a noninvasive imaging technique,
Neurology March 07,2024
Lack of brain shrinkage may help predict who develops dementia with Lewy bodies

Lack of brain shrinkage may help predict who develops dementia with Lewy bodies

by Mayo ClinicDementia with Lewy bodies is a progressive disease that causes hallucinations, decline in mental abilities, rigid muscles, slow movement and tremors. With symptoms similar to Alzhei
Neurology March 07,2024
Lack of brain shrinkage may help predict who develops dementia with Lewy bodies

Lack of brain shrinkage may help predict who develops dementia with Lewy bodies

by Mayo ClinicDementia with Lewy bodies is a progressive disease that causes hallucinations, decline in mental abilities, rigid muscles, slow movement and tremors. With symptoms similar to Alzhei
Neurology March 07,2024
Study identifies potential biomarker for Alzheimer's disease

Study identifies potential biomarker for Alzheimer's disease

by Boston University Medical CenterIn one of the largest studies to date to use metabolomics, the study of compounds that are created through various chemical reactions in the body, researchers h
Neurology March 07,2024
Study identifies potential biomarker for Alzheimer's disease

Study identifies potential biomarker for Alzheimer's disease

by Boston University Medical CenterIn one of the largest studies to date to use metabolomics, the study of compounds that are created through various chemical reactions in the body, researchers h
Neurology March 07,2024
Targeted preventive measures for hip fracture are needed for persons with Alzheimer's disease

Targeted preventive measures for hip fracture are needed for persons with Alzheimer's disease

by University of Eastern FinlandThe hip fracture risk factors are generally similar among those with and without Alzheimer's disease, according to a recent study from the University of Easter
Neurology March 07,2024
Targeted preventive measures for hip fracture are needed for persons with Alzheimer's disease

Targeted preventive measures for hip fracture are needed for persons with Alzheimer's disease

by University of Eastern FinlandThe hip fracture risk factors are generally similar among those with and without Alzheimer's disease, according to a recent study from the University of Easter
Neurology March 07,2024
Research highlights misdiagnosis for people with Alzheimer's disease

Research highlights misdiagnosis for people with Alzheimer's disease

by Alzheimer's Research UKResearch presented today (Tuesday 26 July) at the Alzheimer's Association International Conference 2016 suggests that men with Alzheimer's may be more likely
Neurology March 07,2024
Research highlights misdiagnosis for people with Alzheimer's disease

Research highlights misdiagnosis for people with Alzheimer's disease

by Alzheimer's Research UKResearch presented today (Tuesday 26 July) at the Alzheimer's Association International Conference 2016 suggests that men with Alzheimer's may be more likely
Neurology March 07,2024
Researchers develop combined data model to better evaluate for mild cognitive impairment

Researchers develop combined data model to better evaluate for mild cognitive impairment

by Boston University School of MedicineA new study has shown that by combining imaging and neuropsychological testing, one can more accurately assess the cognitive status of individuals.Cognitive
Neurology March 07,2024
Researchers develop combined data model to better evaluate for mild cognitive impairment

Researchers develop combined data model to better evaluate for mild cognitive impairment

by Boston University School of MedicineA new study has shown that by combining imaging and neuropsychological testing, one can more accurately assess the cognitive status of individuals.Cognitive
Neurology March 07,2024
Genetic and non-genetic resilience against memory decline and Alzheimer's

Genetic and non-genetic resilience against memory decline and Alzheimer's

by Alzheimer's Research UKResearchers across the world are keen to understand why some people experience memory decline or diseases like Alzheimer's, while others don't. At AAIC2016,
Neurology March 07,2024
Genetic and non-genetic resilience against memory decline and Alzheimer's

Genetic and non-genetic resilience against memory decline and Alzheimer's

by Alzheimer's Research UKResearchers across the world are keen to understand why some people experience memory decline or diseases like Alzheimer's, while others don't. At AAIC2016,
Neurology March 07,2024
Antipsychotic drug use increases risk of mortality among persons with Alzheimer's disease

Antipsychotic drug use increases risk of mortality among persons with Alzheimer's disease

by University of Eastern FinlandAntipsychotic drug use is associated with a 60 percent increased risk of mortality among persons with Alzheimer's disease, shows a recent study from the Univer
Neurology March 07,2024
Antipsychotic drug use increases risk of mortality among persons with Alzheimer's disease

Antipsychotic drug use increases risk of mortality among persons with Alzheimer's disease

by University of Eastern FinlandAntipsychotic drug use is associated with a 60 percent increased risk of mortality among persons with Alzheimer's disease, shows a recent study from the Univer
Neurology March 07,2024
Use of feeding tubes decreases among nursing home residents with advanced dementia

Use of feeding tubes decreases among nursing home residents with advanced dementia

by The JAMA Network JournalsIn a study appearing in the August 16 issue ofJAMA, Susan L. Mitchell, M.D., M.P.H., of Hebrew SeniorLife Institute for Aging Research, Harvard Medical School, B
Neurology March 07,2024
Use of feeding tubes decreases among nursing home residents with advanced dementia

Use of feeding tubes decreases among nursing home residents with advanced dementia

by The JAMA Network JournalsIn a study appearing in the August 16 issue ofJAMA, Susan L. Mitchell, M.D., M.P.H., of Hebrew SeniorLife Institute for Aging Research, Harvard Medical School, B
Neurology March 07,2024
Antidepressant use increases risk of head injuries among persons with Alzheimer's disease

Antidepressant use increases risk of head injuries among persons with Alzheimer's disease

by University of Eastern FinlandAntidepressant use is associated with an increased risk of head injuries and traumatic brain injuries among persons with Alzheimer's disease, according to a ne
Neurology March 07,2024
Antidepressant use increases risk of head injuries among persons with Alzheimer's disease

Antidepressant use increases risk of head injuries among persons with Alzheimer's disease

by University of Eastern FinlandAntidepressant use is associated with an increased risk of head injuries and traumatic brain injuries among persons with Alzheimer's disease, according to a ne
Neurology March 07,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com